| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/11/1998 | CA2280135A1 The use of levobupivacaine or ropivacaine in treating migraine |
| 09/09/1998 | EP0862633A1 Virus protein antigens of the jc virus |
| 09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 09/09/1998 | EP0862551A1 Fluoro-substituted benzoylpropionic acid derivatives |
| 09/09/1998 | EP0862462A1 A NOVEL COMBINATION OF A $g(b)-RECEPTOR BLOCKER AND AN OPIOID |
| 09/09/1998 | EP0862460A1 Methods of reducing apolipoprotein e4-induced inhibition of neuron remodeling |
| 09/09/1998 | EP0862457A1 Infusions of neuroprotectants and thrombolytic agents |
| 09/09/1998 | EP0862428A1 Ginkgolides for inhibition of membrane expression |
| 09/09/1998 | EP0862423A1 Pharmaceutical composition for oral delivery |
| 09/09/1998 | EP0716649B1 5-arylindole derivatives |
| 09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
| 09/09/1998 | EP0690845B1 Piperazine derivatives as 5-ht1a ligands |
| 09/09/1998 | EP0591280B1 Use of tetrahydrocarbazole derivatives as 5ht1-receptor agonists |
| 09/09/1998 | EP0589903B1 Aminoalkyl-substituted 5-mercaptothiazoles, their preparation and their use |
| 09/09/1998 | CN1192781A Use of neuro-derived fetal cell lines for tranplantation therapy |
| 09/09/1998 | CN1192684A Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
| 09/09/1998 | CN1192679A Compounds active at a novel side on receptor-operated calcium channel useful for treatment of neurological disorders |
| 09/09/1998 | CN1192436A New-benzylpiperazine compounds, process for their prepn. and pharmaceutical compositions which contain them |
| 09/09/1998 | CN1039717C Method for preparing physostigmine carbamate derivatives |
| 09/09/1998 | CN1039714C Substituted indole derivatives, prepn. method and application thereof |
| 09/08/1998 | US5804686 fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
| 09/08/1998 | US5804586 Therapeutic agents |
| 09/08/1998 | US5804580 Benzoxazine derivatives, methods for obtaining same, and their use as drugs |
| 09/08/1998 | US5804560 Modulates processing of amyloid precursor protein |
| 09/08/1998 | US5804554 Calcium channel blocking polypeptides from filistata hibernalis |
| 09/08/1998 | US5804550 Peptide antagonists at glutamate and NMDA receptors |
| 09/08/1998 | US5804419 Encoded by a polynucleotide sequence; forming hybridization complex with nucleic acid material of sample; detecting complex. |
| 09/08/1998 | US5804399 Incubation; measuring effect of composition on kinase or polynucleotide encoding the kinase |
| 09/07/1998 | CA2202345A1 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl)-2-cyclopenten-1-one useful as an inhibitor of cox-2 |
| 09/03/1998 | WO1998038204A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | WO1998038194A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 09/03/1998 | WO1998038189A1 Oxazolidines as 5-ht2a-antagonists |
| 09/03/1998 | WO1998038187A1 Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
| 09/03/1998 | WO1998038186A1 Quinoxalinediones |
| 09/03/1998 | WO1998038177A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR INHIBITING β-AMYLOID PEPTIDE |
| 09/03/1998 | WO1998038174A1 Pyrazine compounds |
| 09/03/1998 | WO1998038173A1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 09/03/1998 | WO1998038165A1 S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 09/03/1998 | WO1998037885A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 09/03/1998 | WO1998037882A1 Method of using neurotrophic carbamates and ureas |
| 09/03/1998 | WO1998029566A3 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 09/03/1998 | WO1998026770A3 The topical use of kappa opioid agonists to treat ocular pain |
| 09/03/1998 | WO1998024804A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 09/03/1998 | CA2282729A1 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/03/1998 | CA2281096A1 Method of using neurotrophic carbamates and ureas |
| 09/03/1998 | CA2278674A1 Heterocyclic compounds and their use for inhibiting .beta.-amyloid peptide |
| 09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
| 09/02/1998 | EP0861837A1 2-Aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/02/1998 | EP0861261A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861257A1 Spiro piperidine derivatives as 5mt receptor antagonists |
| 09/02/1998 | EP0861256A1 1-azabicycloheptane derivatives and their pharmaceutical use |
| 09/02/1998 | EP0861252A1 NAPHTHAMIDE DERIVATIVES OF 3 $g(b)-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS |
| 09/02/1998 | EP0861251A1 Morpholine derivatives and their use as therapeutic agents |
| 09/02/1998 | EP0861250A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 09/02/1998 | EP0861248A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 09/02/1998 | EP0861246A1 Prolylendopeptidase inhibitors |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861235A1 Substituted benzylaminopiperidine compounds |
| 09/02/1998 | EP0861234A1 Enantiomers of cis-benz e]indole compounds, their preparation and utility as dopamine-d3 receptor selective agents |
| 09/02/1998 | EP0861081A1 Use of epinastine in the treatment of pain |
| 09/02/1998 | EP0861075A1 Analgesic compounds and uses thereof |
| 09/02/1998 | EP0766696B1 Thiazolidine derivatives, their preparation and drugs containing same |
| 09/02/1998 | EP0593511B1 Piperidine derivates having anxiolytic effect |
| 09/02/1998 | CN1192246A Cell line producing analgesic compounds for treating pain |
| 09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
| 09/02/1998 | CN1192199A 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1192144A 1H-4(5)-substituted imidazole derivatives |
| 09/02/1998 | CN1191898A Self-enhancing, pharmacologically controllable expression systems |
| 09/02/1998 | CN1191862A 8-substituted-1,3,8-triaza-spiro £4,5| decan-4-on derivatives |
| 09/02/1998 | CN1191742A Epilepsy curing powder |
| 09/02/1998 | CN1039644C Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds and its application |
| 09/02/1998 | CN1039622C New use for large ring lactone compound |
| 09/01/1998 | US5801201 1-phenyl-2-dimenthylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients |
| 09/01/1998 | US5801199 Pharmaceutical composition for treating acute rhinitis |
| 09/01/1998 | US5801197 Rotamase enzyme activity inhibitors |
| 09/01/1998 | US5801190 Fused pyrrolo 2,3-C! carbazole-6-ones |
| 09/01/1998 | US5801187 Heterocyclic esters and amides |
| 09/01/1998 | US5801183 Heterocyclc alcohols for nervous system disorders |
| 09/01/1998 | US5801179 Treatment of migraines, hypotension, venous insufficiency |
| 09/01/1998 | US5801176 Substituted benzothienylpiperazines and their use |
| 09/01/1998 | US5801174 Cerebrovascular disorders |
| 09/01/1998 | US5801171 Use of 3, 5-diamino-6-(2,3-dichlorophenyl)-1, 2, 4-triazine isethionate for the treatment and prevention of dependence; tolerance and sensitization of drugs |
| 09/01/1998 | US5801170 Heterocyclic biphenylylamides useful as 5HT1D antagonists |
| 09/01/1998 | US5800980 Detection of MSRV1 virus and MSRV2 pathogen and/or infective agent associated with multiple sclerosis, by nucleic acid hybridization |
| 09/01/1998 | US5800812 Methods of use of mononuclear phagocytes to promote axonal regeneration |
| 09/01/1998 | US5800808 Copolymer-1 improvements in compositions of copolymers |
| 09/01/1998 | CA2166903C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 08/28/1998 | CA2229707A1 N-oxides of heterocyclic esters, amides, thioesters, and ketones |
| 08/27/1998 | WO1998037411A1 Assay for disease related conformation of a protein |
| 08/27/1998 | WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 08/27/1998 | WO1998037085A1 Netrin receptors |
| 08/27/1998 | WO1998037082A1 7a-HETEROCYCLE-SUBSTITUTED HEXAHYDRO-1H-PYRROLIZINE COMPOUNDS USEFUL IN CONTROLLING CHEMICAL SYNAPTIC TRANSMISSION |
| 08/27/1998 | WO1998037079A1 N-heterocyclic derivatives as nos inhibitors |
| 08/27/1998 | WO1998037071A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| 08/27/1998 | WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 08/27/1998 | WO1998036764A2 Method of treating psychological and metabolic disorders using igf or igf/igfbp-3 |
| 08/27/1998 | WO1998036746A1 Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury |
| 08/27/1998 | WO1998036728A2 Sustained analgesia achieved with buprenorphine |